In summary, we showed in this study that RARRES1 cytoplasmic/negative and AGBL2-positive/negative staining is a significant risk factor for tumour progression indicating 11–15 times higher risk of cancer relapse, whereas the membranous RARRES1 expression, especially its co-expression with AGBL2, is associated with excellent disease outcome. Here, AGBL2 is linked to neoplasm.